• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用一锅法SELEX和高通量测序筛选用于卵巢癌生物标志物CA125的DNA适配体

Selection of DNA Aptamers for Ovarian Cancer Biomarker CA125 Using One-Pot SELEX and High-Throughput Sequencing.

作者信息

Scoville Delia J, Uhm Tae Kyu Brian, Shallcross Jamie A, Whelan Rebecca J

机构信息

Department of Chemistry and Biochemistry, Oberlin College, 119 Woodland Street, Oberlin, OH 44074, USA.

出版信息

J Nucleic Acids. 2017;2017:9879135. doi: 10.1155/2017/9879135. Epub 2017 Feb 9.

DOI:10.1155/2017/9879135
PMID:28280637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5322571/
Abstract

CA125 is a mucin glycoprotein whose concentration in serum correlates with a woman's risk of developing ovarian cancer and also indicates response to therapy in diagnosed patients. Accurate detection of this large, complex protein in patient samples is of great clinical relevance. We suggest that powerful new diagnostic tools may be enabled by the development of nucleic acid aptamers with affinity for CA125. Here, we report on our use of One-Pot SELEX to isolate single-stranded DNA aptamers with affinity for CA125, followed by high-throughput sequencing of the selected oligonucleotides. This data-rich approach, combined with bioinformatics tools, enabled the entire selection process to be characterized. Using fluorescence anisotropy and affinity probe capillary electrophoresis, the binding affinities of four aptamer candidates were evaluated. Two aptamers, CA125_1 and CA125_12, both without primers, were found to bind to clinically relevant concentrations of the protein target. Binding was differently influenced by the presence of Mg ions, being required for binding of CA125_1 and abrogating binding of CA125_12. In conclusion, One-Pot SELEX was found to be a promising selection method that yielded DNA aptamers to a clinically important protein target.

摘要

CA125是一种粘蛋白糖蛋白,其血清浓度与女性患卵巢癌的风险相关,并且在已确诊患者中还可指示对治疗的反应。在患者样本中准确检测这种大型复杂蛋白具有重大临床意义。我们认为,开发对CA125具有亲和力的核酸适体可能会带来强大的新诊断工具。在此,我们报告了使用单步指数富集配体系统进化技术(One-Pot SELEX)分离对CA125具有亲和力的单链DNA适体,随后对所选寡核苷酸进行高通量测序。这种数据丰富的方法与生物信息学工具相结合,能够对整个筛选过程进行表征。使用荧光各向异性和亲和探针毛细管电泳评估了四种适体候选物的结合亲和力。发现两种适体CA125_1和CA125_12(均无引物)可结合临床相关浓度下的蛋白质靶标。镁离子的存在对结合有不同影响,CA125_1的结合需要镁离子,而镁离子会消除CA125_12的结合。总之,单步指数富集配体系统进化技术被发现是一种很有前景的筛选方法,能够产生针对临床重要蛋白质靶标的DNA适体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/161b/5322571/283e1ad94d10/JNA2017-9879135.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/161b/5322571/e77a6f1eb6cb/JNA2017-9879135.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/161b/5322571/410701c4b16e/JNA2017-9879135.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/161b/5322571/2d60132e5570/JNA2017-9879135.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/161b/5322571/1d3fe9894c7e/JNA2017-9879135.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/161b/5322571/283e1ad94d10/JNA2017-9879135.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/161b/5322571/e77a6f1eb6cb/JNA2017-9879135.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/161b/5322571/410701c4b16e/JNA2017-9879135.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/161b/5322571/2d60132e5570/JNA2017-9879135.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/161b/5322571/1d3fe9894c7e/JNA2017-9879135.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/161b/5322571/283e1ad94d10/JNA2017-9879135.005.jpg

相似文献

1
Selection of DNA Aptamers for Ovarian Cancer Biomarker CA125 Using One-Pot SELEX and High-Throughput Sequencing.使用一锅法SELEX和高通量测序筛选用于卵巢癌生物标志物CA125的DNA适配体
J Nucleic Acids. 2017;2017:9879135. doi: 10.1155/2017/9879135. Epub 2017 Feb 9.
2
Selection of DNA aptamers for ovarian cancer biomarker HE4 using CE-SELEX and high-throughput sequencing.使用毛细管电泳-指数富集配体系统进化技术(CE-SELEX)和高通量测序筛选用于卵巢癌生物标志物人附睾蛋白4(HE4)的DNA适配体
Anal Bioanal Chem. 2015 Sep;407(23):6965-73. doi: 10.1007/s00216-015-8665-7. Epub 2015 Apr 12.
3
[Efficient screening for 8-oxoguanine DNA glycosylase binding aptamers via capillary electrophoresis].[通过毛细管电泳高效筛选8-氧代鸟嘌呤DNA糖基化酶结合适体]
Se Pu. 2021 Jul 8;39(7):721-729. doi: 10.3724/SP.J.1123.2020.12017.
4
In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing.针对卵巢癌中CA125肿瘤标志物的RNA适体的体外筛选及其光学生物传感研究。
Methods. 2016 Mar 15;97:58-68. doi: 10.1016/j.ymeth.2015.10.022. Epub 2015 Nov 2.
5
An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.一种用于筛选与化脓性链球菌M11型结合的DNA适配体的改良SELEX技术。
Methods. 2016 Mar 15;97:51-7. doi: 10.1016/j.ymeth.2015.12.005. Epub 2015 Dec 8.
6
Screening and Identification of DNA Aptamers to Tyramine Using in Vitro Selection and High-Throughput Sequencing.利用体外筛选和高通量测序技术筛选和鉴定酪胺的DNA适配体
ACS Comb Sci. 2016 Jun 13;18(6):302-13. doi: 10.1021/acscombsci.5b00163. Epub 2016 Apr 26.
7
Novel ssDNA Ligand Against Ovarian Cancer Biomarker CA125 With Promising Diagnostic Potential.新型抗卵巢癌生物标志物CA125的单链DNA配体具有潜在的诊断价值。
Front Chem. 2020 May 15;8:400. doi: 10.3389/fchem.2020.00400. eCollection 2020.
8
One-Pot SELEX: Identification of Specific Aptamers against Diverse Steroid Targets in One Selection.一锅法SELEX:在一次筛选中鉴定针对多种类固醇靶标的特异性适配体。
ACS Omega. 2019 Nov 20;4(23):20188-20196. doi: 10.1021/acsomega.9b02412. eCollection 2019 Dec 3.
9
Characterisation of aptamer-target interactions by branched selection and high-throughput sequencing of SELEX pools.通过分支选择和SELEX文库的高通量测序对适体-靶标相互作用进行表征。
Nucleic Acids Res. 2015 Dec 2;43(21):e139. doi: 10.1093/nar/gkv700. Epub 2015 Jul 10.
10
Glycan-Imprinted Magnetic Nanoparticle-Based SELEX for Efficient Screening of Glycoprotein-Binding Aptamers.糖基印迹磁性纳米粒子 SELEX 用于高效筛选糖蛋白结合适体。
ACS Appl Mater Interfaces. 2018 Nov 28;10(47):40918-40926. doi: 10.1021/acsami.8b14441. Epub 2018 Nov 13.

引用本文的文献

1
Early-Stage Pancreatic Cancer Diagnosis: Serum Biomarkers and the Potential for Aptamer-Based Biosensors.早期胰腺癌诊断:血清生物标志物及基于适配体的生物传感器的潜力
Molecules. 2025 Apr 30;30(9):2012. doi: 10.3390/molecules30092012.
2
Current developments of SELEX technologies and prospects in the aptamer selection with clinical applications.SELEX技术的当前发展以及适体筛选在临床应用中的前景。
J Genet Eng Biotechnol. 2024 Sep;22(3):100400. doi: 10.1016/j.jgeb.2024.100400. Epub 2024 Jul 25.
3
Generation of epitope-specific hCG aptamers through a novel targeted selection approach.

本文引用的文献

1
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.英国卵巢癌筛查协作试验(UKCTOCS)中的卵巢癌筛查与死亡率:一项随机对照试验
Lancet. 2016 Mar 5;387(10022):945-956. doi: 10.1016/S0140-6736(15)01224-6. Epub 2015 Dec 17.
2
In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing.针对卵巢癌中CA125肿瘤标志物的RNA适体的体外筛选及其光学生物传感研究。
Methods. 2016 Mar 15;97:58-68. doi: 10.1016/j.ymeth.2015.10.022. Epub 2015 Nov 2.
3
Selection of DNA aptamers for ovarian cancer biomarker HE4 using CE-SELEX and high-throughput sequencing.
通过一种新的靶向选择方法生成表位特异性 hCG 适体。
PLoS One. 2024 Feb 23;19(2):e0295673. doi: 10.1371/journal.pone.0295673. eCollection 2024.
4
A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing.长读测序技术推动卵巢癌生物标志物 CA125(MUC16)分子模型的修订。
Cancer Res Commun. 2024 Jan 31;4(1):253-263. doi: 10.1158/2767-9764.CRC-23-0327.
5
Bio-SELEX: A Strategy for Biomarkers Isolation Directly from Biological Samples.生物系统进化配体指数富集技术:一种直接从生物样本中分离生物标志物的策略。
Methods Protoc. 2023 Nov 11;6(6):109. doi: 10.3390/mps6060109.
6
Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges.适体作为卵巢癌潜在治疗工具:进展与挑战
Cancers (Basel). 2023 Nov 6;15(21):5300. doi: 10.3390/cancers15215300.
7
Fabrication of mesoporous silica nanoparticles for targeted delivery of sunitinib to ovarian cancer cells.用于将舒尼替尼靶向递送至卵巢癌细胞的介孔二氧化硅纳米颗粒的制备。
Bioimpacts. 2023;13(3):255-267. doi: 10.34172/bi.2023.25298. Epub 2023 Jan 23.
8
Applications of Aptamers in the Diagnosis and Treatment of Ovarian Cancer: Progress From 2016 to 2020.适体在卵巢癌诊断与治疗中的应用:2016年至2020年的进展
Front Genet. 2021 Sep 13;12:683542. doi: 10.3389/fgene.2021.683542. eCollection 2021.
9
Implementation of High-Throughput Sequencing (HTS) in Aptamer Selection Technology.高通量测序(HTS)在适体筛选技术中的应用
Int J Mol Sci. 2020 Nov 20;21(22):8774. doi: 10.3390/ijms21228774.
10
Chemical Modification of Aptamers for Increased Binding Affinity in Diagnostic Applications: Current Status and Future Prospects.适体的化学修饰提高诊断应用中的结合亲和力:现状与未来展望。
Int J Mol Sci. 2020 Jun 25;21(12):4522. doi: 10.3390/ijms21124522.
使用毛细管电泳-指数富集配体系统进化技术(CE-SELEX)和高通量测序筛选用于卵巢癌生物标志物人附睾蛋白4(HE4)的DNA适配体
Anal Bioanal Chem. 2015 Sep;407(23):6965-73. doi: 10.1007/s00216-015-8665-7. Epub 2015 Apr 12.
4
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.MUC16(CA125):癌症治疗的肿瘤生物标志物,一项正在进行的工作。
Mol Cancer. 2014 May 29;13:129. doi: 10.1186/1476-4598-13-129.
5
Tracking the emergence of high affinity aptamers for rhVEGF165 during capillary electrophoresis-systematic evolution of ligands by exponential enrichment using high throughput sequencing.在高通量测序的指数富集配体系统进化中,通过毛细管电泳跟踪高亲和力适体对 rhVEGF165 的出现。
Anal Chem. 2013 Nov 19;85(22):10761-70. doi: 10.1021/ac401875h. Epub 2013 Nov 1.
6
OC125, M11 and OV197 epitopes are not uniformly distributed in the tandem-repeat region of CA125 and require the entire SEA domain.OC125、M11 和 OV197 表位在 CA125 的串联重复区中不是均匀分布的,需要整个 SEA 结构域。
Dis Markers. 2013;34(4):257-67. doi: 10.3233/DMA-130968.
7
Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection.基于细胞的适体筛选的生物信息学分析快速鉴定细胞特异性内化 RNA 适体。
PLoS One. 2012;7(9):e43836. doi: 10.1371/journal.pone.0043836. Epub 2012 Sep 4.
8
Methods for measuring aptamer-protein equilibria: a review.测量适体-蛋白质平衡的方法:综述
Anal Chim Acta. 2011 Feb 7;686(1-2):9-18. doi: 10.1016/j.aca.2010.10.032. Epub 2010 Nov 10.
9
Noncooled capillary inlet: a source of systematic errors in capillary-electrophoresis-based affinity analyses.非冷却毛细管入口:基于毛细管电泳的亲和分析中系统误差的一个来源。
Anal Chem. 2010 Oct 15;82(20):8637-41. doi: 10.1021/ac1018364.
10
Mucins in cancer: function, prognosis and therapy.黏蛋白在癌症中的作用、预后和治疗。
Nat Rev Cancer. 2009 Dec;9(12):874-85. doi: 10.1038/nrc2761.